*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
Jurkat , Jurkat (10 μM Etoposide treatment for 24hr) , Lovo , Lovo (200 ng/ml EGF treatment for 0.5 hr)
Mouse, Rat(>80% identity)
1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1.47 mg/ml (Please refer to the vial label for the specific concentration.)
Recombinant protein encompassing a sequence within the center region of human FNBP1L. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
formin binding protein 1 like , C1orf39 , TOCA1
Cytoplasm , cytoskeleton , cell cortex , Cytoplasmic vesicle , Cell membrane; Peripheral membrane protein; Cytoplasmic side
The protein encoded by this gene binds to both CDC42 and N-WASP. This protein promotes CDC42-induced actin polymerization by activating the N-WASP-WIP complex and, therefore, is involved in a pathway that links cell surface signals to the actin cytoskeleton. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq]
GTX132563 WB Image
Untreated (–) and treated (+) LoVo whole cell extracts (60 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with FNBP1L antibody (GTX132563) diluted at 1:1000.
GTX132563 WB Image
Untreated (–) and treated (+) Jurkat whole cell extracts (30 μg) were separated by 7.5% SDS-PAGE, and the membrane was blotted with FNBP1L antibody (GTX132563) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.